IPP Bureau
Sai Life Sciences opens discovery biology facility in Hyderabad
By IPP Bureau - August 19, 2021
The company's discovery services support a wide range of global innovator companies from start-ups to large pharma companies, across a diverse set of therapeutic areas including oncology, CNS, antivirals, and inflammation among others
MedAlliance enrols patients for ED study with Sirolimus Drug-Eluting Balloon
By IPP Bureau - August 19, 2021
It is estimated that 300 million men worldwide were affected by ED in 2020, a figure projected to increase to 322 million by 2025. Nearly 30% of these were aged between 40 and 70
FDA grants breakthrough device designation to Impella ECP, the world’s smallest heart pump
By IPP Bureau - August 19, 2021
It measures 9 French (3 millimetres) in diameter upon insertion and removal from the body. While in the heart, it expands to support the heart’s pumping function, providing flow greater than 3.5 L/min
FDA grants Emergency Use Authorization for next-generation Covid-19 assays
By IPP Bureau - August 19, 2021
Thermo Fisher’s kits leverage an updated design from the original TaqPath assays, targeting eight different genes across three regions of the virus that causes Covid-19
Finding a cure for HIV
By IPP Bureau - August 19, 2021
The group, known as the HIV Obstruction by Programmed Epigenetics (HOPE) Collaboratory, will be led by researchers at Gladstone Institutes, Scripps Research Florida, and Weill Cornell Medicine. Their approach, which aims to both silence and permanently remove HIV from the body, takes advantage of knowledge about how other viruses have become naturally inactivated over time.
Ind-Ra predicts growth in US sales for Indian pharma from H2FY22
By IPP Bureau - August 18, 2021
Price erosion, weak demand for acute portfolio and low ANDA approvals in the US weighed on the performance of Indian pharma in Q1FY22. However, the scenario is expected to change in H2FY22 when new approvals and inspections resume
ANG Lifesciences acquires Ind-Swift formulation facilities for Rs 60 cr
By IPP Bureau - August 18, 2021
The company expects a potential sales turnover of Rs.350-500 crores at 100 % capacity utilization
Swastika Investmart and Medcords Healthcare join hands to finance medical stores
By IPP Bureau - August 18, 2021
Through the Sehat Sathi App business can access unsecured business loans at low interest
Wellness Forever Medicare expands its presence as it opens 15 new stores
By IPP Bureau - August 18, 2021
It strengthens its presence to over 250 stores
EpiEndo Pharma secures EUR 20 Million Series A funding for Macrolide
By IPP Bureau - August 18, 2021
The financing secures funds to advance the clinical development of EpiEndo’s lead compound EP395, which entered phase I clinical trials in April, through Phase IIa, targeting COPD as a primary indication
Novartis secures new approval in China for Cosentyx in pediatric psoriasis
By IPP Bureau - August 18, 2021
Cosentyx is a proven treatment, supported by long-term five-year sustained efficacy and safety data across several inflammatory conditions and with more than 500,000 patients treated worldwide since launch
Novartis announces positive results from Phase 3 trials of Beovu for diabetes
By IPP Bureau - August 18, 2021
Results from year two of the pivotal Phase 3 KITE clinical trial reaffirmed visual acuity gains and fluid reduction findings as well as safety profile from year one
Real world data from Paraguay shows one-shot Sputnik Light vaccine has high safety and efficacy of 93.5 %
By IPP Bureau - August 18, 2021
Sputnik Light is the first component (recombinant human adenovirus serotype number 26 (rAd26)) of Sputnik
Apollo Children’s hospital saves new born with rare brain vascular malformation
By IPP Bureau - August 18, 2021
Seen in 1 in 3 million births, the malformation was detected at the antenatal stage during the mother's pregnancy
Test At Home (TAH), offers convenient saliva-based testing for Covid-19
By IPP Bureau - August 18, 2021
TAH is now undergoing regulatory clearance and final quality control procedures for the swab deployment in India, EU, Singapore, UK, US, Australia and others for COVID-19 testing
